11:26 AM EST - Aralez Pharmaceuticals Inc. : Announced financial results for the year ended December 31, 2017. All figures are in U.S. dollars. Full-Year net revenues Increased to $105.9 million versus $54.3 million in 2016. Net loss in the year ended December 31, 2017 was $125,205 million, or $1.89 per diluted share, compared to net loss of $103.0 million, or $1.74 per diluted share, in the comparable period of 2016. Aralez Pharmaceuticals Inc.
shares T.ARZ are trading down $0.41 at $2.19.